en
Scientific article
English

Lower Risk of B1-to-pB3-Stage Migration in Crohn's Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study

Published inDigestive Diseases and Sciences, vol. 65, no. 9, p. 2654-2663
Publication date2020
Abstract

While the long-term evolution of disease behavior in Crohn's disease has been well described in the pre-anti-TNF era, our knowledge thereon remains scarce after the introduction of anti-TNF.

Keywords
  • Crohn's disease
  • Disease-modifying
  • Immunosuppressive agents
  • Montreal classification
  • Tumor necrosis factor-alpha
Funding
  • Swiss National Science Foundation - 3347CO-108792
Citation (ISO format)
CERNOCH, Patrick S et al. Lower Risk of B1-to-pB3-Stage Migration in Crohn’s Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study. In: Digestive Diseases and Sciences, 2020, vol. 65, n° 9, p. 2654–2663. doi: 10.1007/s10620-019-05978-9
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0163-2116
131views
0downloads

Technical informations

Creation10/15/2020 5:22:00 PM
First validation10/15/2020 5:22:00 PM
Update time03/16/2023 12:37:21 AM
Status update03/16/2023 12:37:21 AM
Last indexation01/17/2024 1:17:12 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack